Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Semaglutide on Osteoporotic Fractures in Patients With Type 2 Diabetes

NCT07165158 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT07165158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07165158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Semaglutide on Osteoporotic Fractures in Patients With Type 2 Diabetes
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 15, 2025
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, osteoporosis fracture, t2dm